Compound Evidence File
#EC-2026-0803
GW-501516 (Cardarine)
Filed under Oral Tablets. The bureau holds 57 laboratory returns for this compound from 29 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
29 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Paradigm PeptideCASE #VI-2026-0759 | X | 1 | 10.0 | 10.0 | 10.0 | 20 Jun 2025 | 20 Jun 2025 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 9.6 | 9.6 | 9.6 | 2 Apr 2025 | 2 Apr 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 7 | 8.9 | 7.5 | 10.0 | 24 May 2026 | 24 May 2026 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 8.9 | 8.9 | 8.9 | 3 Jul 2025 | 3 Jul 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 8.8 | 7.5 | 10.0 | 23 May 2026 | 23 May 2026 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 8.8 | 8.8 | 8.8 | 7 May 2025 | 7 May 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 8.7 | 8.1 | 9.3 | 24 May 2026 | 24 May 2026 |
| Huayi BiotechnologyCASE #VI-2026-0243 | X | 1 | 8.7 | 8.7 | 8.7 | 16 Mar 2025 | 16 Mar 2025 |
| Trusted PeptideCASE #VI-2026-0499 | X | 1 | 8.5 | 8.5 | 8.5 | 21 May 2025 | 21 May 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.3 | 8.1 | 8.7 | 24 May 2026 | 24 May 2026 |
| AKS ChemCASE #VI-2026-0313 | X | 1 | 8.2 | 8.2 | 8.2 | 27 Feb 2025 | 27 Feb 2025 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 8.2 | 8.2 | 8.2 | 21 May 2025 | 21 May 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.1 | 7.2 | 10.0 | 25 May 2026 | 25 May 2026 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 8.0 | 8.0 | 8.0 | 2 Apr 2025 | 2 Apr 2025 |
| Pure Tested PeptidesCASE #VI-2026-0225 | X | 1 | 7.8 | 7.8 | 7.8 | 3 Jun 2025 | 3 Jun 2025 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | X | 1 | 7.8 | 7.8 | 7.8 | 8 Jul 2025 | 8 Jul 2025 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 7.6 | 7.6 | 7.6 | 3 Jun 2025 | 3 Jun 2025 |
| Forever Young PharmacyCASE #VI-2026-0654 | X | 1 | 6.4 | 6.4 | 6.4 | 8 Jul 2025 | 8 Jul 2025 |
| Alpha-GenCASE #VI-2026-0905 | X | 3 | 6.0 | 5.3 | 6.7 | 2 Apr 2025 | 26 Jan 2026 |
| Heman Peptide HMCASE #VI-2026-0089 | X | 1 | 5.9 | 5.9 | 5.9 | 17 Dec 2024 | 17 Dec 2024 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 1 | 5.4 | 5.4 | 5.4 | 21 May 2025 | 21 May 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 1 | 5.3 | 5.3 | 5.3 | 2 Apr 2025 | 2 Apr 2025 |
| Biolongevity LabsCASE #VI-2026-0442 | X | 2 | 4.8 | 2.2 | 7.4 | 3 Jul 2025 | 24 May 2026 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 1 | 4.8 | 4.8 | 4.8 | 11 Jun 2025 | 11 Jun 2025 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 1 | 4.7 | 4.7 | 4.7 | 9 Jun 2025 | 9 Jun 2025 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 4.1 | 4.1 | 4.1 | 13 Jun 2025 | 13 Jun 2025 |
| Peptide ArkCASE #VI-2026-0350 | X | 1 | 0.2 | 0.2 | 0.2 | 3 Jul 2025 | 3 Jul 2025 |
Open any subject to view the batch-level evidence for GW-501516 (Cardarine) alone.